German Pharmaceuticals & Biotech Healthy potentially undervalued

SCHOTT Pharma KGaA

Market Cap: €2.7b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Bayer

Market Cap: €49.1b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Merck KGaA

Market Cap: €60.6b

Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

Evotec

Market Cap: €863.9m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Dermapharm Holding

Market Cap: €2.3b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Formycon

Market Cap: €327.3m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.